Education
About Us
Working with TipRanks
Follow Us
Pharma Foods International Co., Ltd. (JP:2929)
:2929
2929 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥722.00 - ¥1,254.00
Previous CloseN/A
Volume159.60K
Average Volume (3M)145.16K
Market Cap
¥25.93B
Enterprise Value¥29.99B
Total Cash (Recent Filing)¥4.09B
Total Debt (Recent Filing)¥2.44B
Price to Earnings (P/E)9.4
Beta0.96
Next Earnings
Jun 05, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jul 30, 2025Dividend Yield3.13%
Share Statistics
EPS (TTM)95.13
Shares Outstanding29,079,000
10 Day Avg. Volume100,830
30 Day Avg. Volume145,160
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Pharma Foods International Co., Ltd. News
PremiumCompany Announcements
Pharma Foods Reports Decline in Six-Month Financial Performance
PremiumCompany Announcements
Pharma Foods Reports Rising Profits Amid Sales Decline
PremiumCompany Announcements
Pharma Foods Reports Higher Profits Despite Sales Dip---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.52%
Mutual Funds
― Other Institutional Investors
95.16% Public Companies and
Individual Investors
2929 FAQ
What was Pharma Foods International Co., Ltd.’s price range in the past 12 months?
Pharma Foods International Co., Ltd. lowest stock price was ¥722.00 and its highest was ¥1254.00 in the past 12 months.
What is Pharma Foods International Co., Ltd.’s market cap?
Pharma Foods International Co., Ltd.’s market cap is ¥25.93B.
When is Pharma Foods International Co., Ltd.’s upcoming earnings report date?
Pharma Foods International Co., Ltd.’s upcoming earnings report date is Jun 05, 2025 which is in 42 days.
How were Pharma Foods International Co., Ltd.’s earnings last quarter?
Pharma Foods International Co., Ltd. released its earnings results on Mar 12, 2025. The company reported -¥4.8 earnings per share for the quarter, missing the consensus estimate of N/A by -¥4.8.
Is Pharma Foods International Co., Ltd. overvalued?
According to Wall Street analysts Pharma Foods International Co., Ltd.’s price is currently Overvalued.
Does Pharma Foods International Co., Ltd. pay dividends?
Pharma Foods International Co., Ltd. pays a Annually dividend of ¥12.5 which represents an annual dividend yield of 3.13%. See more information on Pharma Foods International Co., Ltd. dividends here
What is Pharma Foods International Co., Ltd.’s EPS estimate?
Pharma Foods International Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharma Foods International Co., Ltd. have?
Pharma Foods International Co., Ltd. has 29,079,000 shares outstanding.
What happened to Pharma Foods International Co., Ltd.’s price movement after its last earnings report?
Pharma Foods International Co., Ltd. reported an EPS of -¥4.8 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.65%.
Which hedge fund is a major shareholder of Pharma Foods International Co., Ltd.?
Currently, no hedge funds are holding shares in JP:2929
---
Company Description
Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.
---
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Chugai Pharmaceutical Co
―
ONO Pharmaceutical Co
―
Takeda Pharmaceutical Co
―
Daiichi Sankyo Company
―
---